Article Versions Notes

Serie DJ, Crook JE, Necela BM, Axenfeld BC, Dockter TJ, Colon-Otero G, Perez EA, Thompson EA, Norton N. Breast Cancer Clinical Trial of Chemotherapy and Trastuzumab: Potential Tool to Identify Cardiac Modifying Variants of Dilated Cardiomyopathy. Journal of Cardiovascular Development and Disease. 2017; 4(2):6. https://doi.org/10.3390/jcdd4020006

Serie, Daniel J., Julia E. Crook, Brian M. Necela, Bianca C. Axenfeld, Travis J. Dockter, Gerardo Colon-Otero, Edith A. Perez, E. Aubrey Thompson, and Nadine Norton. 2017. "Breast Cancer Clinical Trial of Chemotherapy and Trastuzumab: Potential Tool to Identify Cardiac Modifying Variants of Dilated Cardiomyopathy" Journal of Cardiovascular Development and Disease 4, no. 2: 6. https://doi.org/10.3390/jcdd4020006

Serie, D. J., Crook, J. E., Necela, B. M., Axenfeld, B. C., Dockter, T. J., Colon-Otero, G., Perez, E. A., Thompson, E. A., & Norton, N. (2017). Breast Cancer Clinical Trial of Chemotherapy and Trastuzumab: Potential Tool to Identify Cardiac Modifying Variants of Dilated Cardiomyopathy. Journal of Cardiovascular Development and Disease, 4(2), 6. https://doi.org/10.3390/jcdd4020006